IMPEL PHARMACEUTICALS INC (IMPLQ)
Institutional ownership reported to the SEC as of Q4 2023, across 11 quarters.
2
Reporting holders
$341.0K
Reported value
0.0%
Held as options
-28
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| venBio Partners LLC | $340.8K | 2,759,791 | 0.05% | 11q | HELD |
| ST GERMAIN D J CO INC | $185 | 1,500 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2023 | 2 | $341.0K | 2,761,291 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 30 | $7.3M | 17,079,595 | 4 | 4 | 6 | 0.0% |
| Q2 2023 | 31 | $22.3M | 17,540,983 | 1 | 3 | 5 | 0.0% |
| Q1 2023 | 29 | $24.7M | 17,646,036 | 1 | 5 | 6 | 0.0% |
| Q4 2022 | 31 | $55.7M | 14,854,660 | 7 | 3 | 7 | 0.0% |
| Q3 2022 | 34 | $73.9M | 15,168,367 | 3 | 10 | 7 | 0.0% |
| Q2 2022 | 32 | $140.6M | 15,084,974 | 6 | 4 | 13 | 0.0% |
| Q1 2022 | 42 | $95.7M | 15,020,780 | 4 | 11 | 11 | 0.0% |
| Q4 2021 | 44 | $131.8M | 15,271,824 | 12 | 17 | 4 | 0.0% |
| Q3 2021 | 44 | $222.5M | 18,266,255 | 16 | 12 | 9 | 0.0% |
| Q2 2021 | 33 | $149.7M | 16,918,252 | 33 | 0 | 0 | 0.0% |